Sales rise 201.64% to Rs 46.00 crore
Net profit of Indrayani Biotech rose 199.13% to Rs 3.44 crore in the quarter ended December 2022 as against Rs 1.15 crore during the previous quarter ended December 2021. Sales rose 201.64% to Rs 46.00 crore in the quarter ended December 2022 as against Rs 15.25 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales46.0015.25 202 OPM %11.5912.13 -PBDT4.201.41 198 PBT3.411.15 197 NP3.441.15 199Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
